Nexentis Technologies (NXTS) Revenue (2019 - 2025)
Nexentis Technologies (NXTS) posted Revenue of $2000.0 for Q3 2025, down 96.97% on a QoQ basis from $66000.0 in Q1 2025, and down 77.78% year-over-year from $9000.0 in Q3 2024.
Analysis
Nexentis Technologies (NXTS) Revenue (2019 - 2025) Analysis & Trends
Nexentis Technologies has reported Revenue for 7 years, with the latest figure at $2000.0 in Q3 2025.
- On a quarterly basis, Revenue fell 77.78% year-over-year to $2000.0 in Q3 2025; TTM through Sep 2025 was $209000.0, a 19.17% increase from a year earlier, with the FY2024 full-year figure at $210000.0, down 20.15% from the prior year.
- Revenue was $2000.0 for Q3 2025 at Nexentis Technologies, down from $66000.0 in the prior quarter.
- The five-year high for Revenue was $224061.0 in Q4 2022, with the low at $2000.0 in Q3 2025.
- Average Revenue over 5 years is $80832.1, with a median of $66000.0 recorded in 2025.
- The sharpest annual moves came in 2021 and 2025: Revenue jumped 93.62% in 2021, then sank 77.78% in 2025.
- Over 5 years, Revenue stood at $189301.0 in 2021, then advanced by 18.36% to $224061.0 in 2022, then tumbled by 52.97% to $105382.0 in 2023, then jumped by 33.8% to $141000.0 in 2024, then slumped by 98.58% to $2000.0 in 2025.
- The last three Revenue figures came in at $2000.0 (Q3 2025), $66000.0 (Q1 2025), and $141000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Nexentis Technologies | 1.40 Mn | -7.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 44,000.00 |
| Dec 31, 2023 | 105,382.00 |
| Jun 30, 2023 | 36,608.00 |
| Mar 31, 2023 | 121,010.00 |
| Dec 31, 2022 | 224,061.00 |
| Sep 30, 2022 | 51,233.00 |
| Jun 30, 2022 | 31,080.00 |
| Mar 31, 2022 | 87,630.00 |
| Dec 31, 2021 | 189,301.00 |
| Sep 30, 2021 | 71,363.00 |
| Jun 30, 2021 | 54,403.00 |
| Mar 31, 2021 | 123,074.00 |
| Dec 31, 2020 | 168,708.00 |
| Mar 31, 2020 | 63,566.00 |
| Dec 31, 2019 | 46,090.00 |